European Archives - Page 359 of 1213 - European Medical Journal

EMJ Hepatology 12.1 2024

In our latest issue of EMJ Hepatology, you can explore a wide range of exclusive interviews with experts in the field, insightful…

Non-Invasive Liver Fibrosis Assessment in Metabolic Dysfunction-Associated Steatotic Liver Disease

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the main cause of liver disease, and its incidence is rising due to the…

Reimagining PBC Care

For patients with the chronic progressive liver disease primary biliary cholangitis (PBC), personalised treatment is key to both…

Review of the European Association for the Study of the Liver (EASL) International Congress 2024

This June, Milan, Italy, became more than the fashion capital of the world; from the 5th–8th June 2024, this historic city housed…

The latest edition of EMJ Hepatology

The brand new issue of EMJ Hepatology journal showcases the latest research in the field, including detailed coverage from the European…

Gut Dysbiosis Associated with the Severity of Liver Fibrosis Assessed by Magnetic Resonance Elastography

The gut microbiome might affect the severity of metabolic dysfunction-associated steatotic liver disease (MASLD);1⁻3 however, data…

Interview: Mario Strazzabosco

The management of liver cancer has changed dramatically during the 4 decades since I started as an internal medicine speciality fellow…

The Next Frontier in Metabolic Dysfunction-Associated Steatotic Liver Disease

THE FUTURE of metabolic-dysfunction associated liver disease (MASLD) was discussed in an insightful session chaired by Hannes Hagström…

Prevention of Decompensation in Compensated Cirrhosis

Portal hypertension is the major determinant of outcomes in patients with cirrhosis, defined as the presence of a hepatic venous pressure…

Healthy Livers, Healthy Lives

NON-COMMUNICABLE diseases (NCD) represent a major global health challenge, with significant mortality and morbidity. Among these…